Trial Profile
A retrospective trial to assess weekly nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in patients with refractory unresectable or metastatic gastric cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Aug 2015
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Gastric cancer
- Focus Adverse reactions; Therapeutic Use
- 09 Aug 2015 New trial record